Follow The Filings

THRY Thryv

Thryv earnings company data as of 9:01 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by THRY's executives, directors and 10% owners in the last 12 months, from their Form 4s

All THRY insider trades
  • $7.6M bought by 5 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Joe Walsh CEO
    Buy
    $45K 25,000 shares at $1.80 +3.3% to stake
    Traded Sep 18 Filed Sep 18
  2. Paulson & Co. Inc. 10% owner
    Buy
    $1.1M 399,548 shares at $2.81 +4.7% to stake
    Traded Aug 4–5 Filed Aug 6
  3. Lou Orfanos Director
    Buy
    $13K 5,000 shares at $2.60 +45% to stake
    Traded Mar 18 Filed Mar 23
  4. John Slater Director
    Buy
    $5,320 2,000 shares at $2.66 +5.2% to stake
    Traded Mar 17 Filed Mar 23
  5. Joe Walsh CEO
    Buy
    $44K 15,000 shares at $2.91 +2% to stake
    Traded Mar 13 Filed Mar 13
  6. John Slater Director
    Buy
    $9,720 3,000 shares at $3.24 +8.5% to stake
    Traded Mar 4 Filed Mar 6
  7. Paul D Rouse CFO
    Buy
    $49K 20,000 shares at $2.43 +6% to stake
    Traded Mar 2–3 Filed Mar 4
  8. Paulson & Co. Inc. 10% owner
    Buy
    $6.1M 2,437,765 shares at $2.50 +41% to stake
    Traded Feb 27–Mar 3 Filed Mar 3
  9. Joe Walsh CEO
    Buy
    $163K 25,000 shares at $6.51 +4.3% to stake
    Traded Nov 7, 2025 Filed Nov 10, 2025
  10. John Slater Director
    Buy
    $11K 1,500 shares at $7.07 +4.4% to stake
    Traded Nov 5, 2025 Filed Nov 7, 2025

Also filed in the last 12 months, not counted as buying or selling: 37 share withholdings for taxes, 16 stock grants, and 1 option exercise.

SEC filings

Recent issuer filings from EDGAR, 14 shown.

Filed Form Detail Links
8-K 1.01,9.01
8-K 5.02,9.01
8-K 2.02,7.01,9.01
10-Q
SCHEDULE 13G —
8-K 5.07
SCHEDULE 13G/A —
DEF 14A
8-K 2.02,7.01,9.01
10-Q
DEFA14A
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.